Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Most Read

  1. ECCMID 2018: Avycaz set for paediatric label expansion following Phase IIb trials
  2. CD40 agonist developments could support Anti-PD-(L)1 therapy in pancreatic cancer
  3. ILC 2018: Allergan’s cenicriviroc shows continued fibrosis response in NASH patients in two year extended study
  4. Public-private partnerships continue to play a critical role in influenza vaccine R&D
  5. Pain takes largest share of clinical trials in 2017

Latest Content

IKA C-MAG HS 7: Designed for Scientists

With hardened glass for maximum visibility and chemical resistance, the IKA C-MAG HS 7 is able to show torque trends, temperature, and speed on an LCD display.

Eligen® Technology Mechanism of Action

Emisphere's Eligen® Technology binds a delivery agent with a therapeutic compound without alternation. This process occurs when both agent and compound are in close proximity.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top